Test-retest variability of [11C]raclopride-binding potential in nontreatment-seeking alcoholics

Synapse

Volumn 65, Issue 7, 2011, Pages 553-561

  Yoder, Karmen K ^a,b   Albrecht, Daniel S ^a,b   Kareken, David A ^a,b   Federici, Lauren M ^a,b   Perry, Kevin M ^a,b   Patton, Elizabeth A ^a,b   Zheng, Qi Huang ^a,b   Mock, Bruce H ^a,b   O'Connor, Sean ^b   Herring, Christine M ^a,b  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Craving; D2 receptor; DA; Nicotine; Positron emission tomography; Striatum

Indexed keywords

RACLOPRIDE C 11;

ADULT; ALCOHOLISM; ARTICLE; BRAIN REGION; CLINICAL ARTICLE; CORPUS STRIATUM; CORRELATION COEFFICIENT; DORSAL CAUDATE; DORSAL PUTAMEN; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TEST RETEST RELIABILITY;

ALCOHOLICS; BRAIN; CARBON RADIOISOTOPES; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; POSITRON-EMISSION TOMOGRAPHY; RACLOPRIDE; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS;

EID: 79953907785     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20874     Document Type: Article

References (44)

1. Bohn MJ, Krahn DD, Staehler BA. 1995. Development and initial validation of a measure of drinking urges in abstinent alcoholics. Alcohol Clin Exp Res 19: 600-606.
2. Brody AL, Olmstead RE, London ED, Farahi J, Meyer JH, Grossman P, Lee GS, Huang J, Hahn EL, Mandelkern MA. 2004. Smoking-induced ventral striatum dopamine release. Am J Psychiatry 161: 1211-1218.
3. Brody AL, Mandelkern MA, Olmstead RE, Scheibal D, Hahn E, Shiraga S, Zamora-Paja E, Farahi J, Saxena S, London ED, McCracken JT. 2006. Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens. Arch Gen Psychiatry 63: 808-816.
4. Bucholz KK, Cadoret R, Cloninger CR, Dinwiddie SH, Hesselbrock VM, Nurnberger JIJr, Reich T, Schmidt I, Schuckit MA. 1994. A new, semi-structured psychiatric interview for use in genetic linkage studies: A report on the reliability of the SSAGA. J Stud Alcohol 55: 149-158.
5. 18F-MPPF PET normative database of 5-HT1A receptor binding in men and women over aging. J Nucl Med 46: 1980-1989.
6. 3H]raclopride in rat and rabbit brains. Equilibrium binding, kinetics, distribution and selectivity. J Pharmacol Exp Ther 250: 696-706.
7. 2 receptor occupancy in alcohol dependent patients with or without physical withdrawal symptoms-A study using IBZM-SPECT. J Neural Transm 109: 1215-1219.
8. Egerton A, Mehta MA, Montgomery AJ, Lappin JM, Howes OD, Reeves SJ, Cunningham VJ, Grasby PM. 2009. The dopaminergic basis of human behaviors: A review of molecular imaging studies. Neurosci Biobehav Rev 33: 1109-1132.
9. Etter JF. 2005. A self-administered questionnaire to measure cigarette withdrawal symptoms: The Cigarette Withdrawal Scale. Nicotine Tob Res 7: 47-57.
10. 11C]raclopride. Synth Commun 34: 1897-1907.
11. Hesselbrock M, Easton C, Bucholz KK, Schuckit M, Hesselbrock V. 1999. A validity study of the SSAGA-A comparison with the SCAN. Addiction 94: 1361-1370.
12. 11C]-raclopride in vivo: A test-retest analysis. J Cereb Blood Flow Metab 19: 210-217.
13. 11C-raclopride. Nucl Med Commun 24: 1207-1214.
14. 11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab 23: 1096-1112.
15. Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, Holden J, Houle S, Huang SC, Ichise M, Iida H, Ito H, Kimura Y, Koeppe RA, Knudsen GM, Knuuti J, Lammertsma AA, Laruelle M, Logan J, Maguire RP, Mintun MA, Morris ED, Parsey R, Price JC, Slifstein M, Sossi V, Suhara T, Votaw JR, Wong DF, Carson RE. 2007. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27: 1533-1539.
16. Laruelle M. 2000. Imaging synaptic neurotransmission with in vivo binding competition techniques: A critical review. J Cereb Blood Flow Metab 20: 423-451.
17. Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL. 1996. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 16: 834-840.
18. Martinez D, Slifstein M, Broft A, Mawlawi O, Hwang DR, Huang Y, Cooper T, Kegeles L, Zarahn E, Abi-Dargham A, Haber SN, Laruelle M. 2003. Imaging human mesolimbic dopamine transmission with positron emission tomography, Part II: Amphetamine-induced dopamine release in the functional subdivisions of the striatum. J Cereb Blood Flow Metab 23: 285-300.
19. Martinez D, Gil R, Slifstein M, Hwang DR, Huang Y, Perez A, Kegeles L, Talbot P, Evans S, Krystal J, Laruelle M, Abi-Dargham A. 2005. Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum. Biol Psychiatry 58: 779-786.
20. 2 receptor parameter measurements in ventral striatum. J Cereb Blood Flow Metab 21: 1034-1057.
21. McGraw KO, Wong SP. 1996. Forming inferences about some intraclass correlation coefficients. Psychol Methods 1: 30-46.
22. Meyerhoff DJ, Tizabi Y, Staley JK, Durazzo TC, Glass JM, Nixon SJ. 2006. Smoking comorbidity in alcoholism: Neurobiological and neurocognitive consequences. Alcohol Clin Exp Res 30: 253-264.
23. NIAAA, editor. 2003. Assessing alcohol problems: A guide for clinicians and researchers. Bethesda, MD, NIH Publication No. 03-3745.
24. O'Connor S, Morzorati S, Christian J, Li TK. 1998. Clamping breath alcohol concentration reduces experimental variance: Application to the study of acute tolerance to alcohol and alcohol elimination rate. Alcohol Clin Exp Res 22: 202-210.
25. Picard F, Bruel D, Servent D, Saba W, Fruchart-Gaillard C, Schollhorn-Peyronneau MA, Roumenov D, Brodtkorb E, Zuberi S, Gambardella A, Steinborn B, Hufnagel A, Valette H, Bottlaender M. 2006. Alteration of the in vivo nicotinic receptor density in ADNFLE patients: A PET study. Brain 129(Pt 8): 2047-2060.
26. Ramchandani VA, Bolane J, Li TK, O'Connor S. 1999. A physiologically-based pharmacokinetic (PBPK) model for alcohol facilitates rapid BrAC clamping. Alcohol Clin Exp Res 23: 617-623.
27. Rice JP, Reich T, Bucholz KK, Neuman RJ, Fishman R, Rochberg N, Hesselbrock VM, Nurnberger JIJr, Schuckit MA, Begleiter H. 1995. Comparison of direct interview and family history diagnoses of alcohol dependence. Alcohol Clin Exp Res 19: 1018-1023.
28. Room R. 2004. Smoking and drinking as complementary behaviours. Biomed Pharmacother 58: 111-115.
29. 11C-raclopride PET. Synapse 28: 66-70.
30. 3H]raclopride: Implications for positron emission tomography of the human brain. Synapse 3: 96-97.
31. Shrout PE, Fleiss JL. 1979. Intraclass correlations: Uses in assessing reliability. Psychol Bull 86: 420-428.
32. Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. 1989. Assessment of alcohol withdrawal: The revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict 84: 1353-1357.
33. Volkow ND, Fowler JS, Wang GJ, Dewey SL, Schlyer D, MacGregor R, Logan J, Alexoff D, Shea C, Hitzemann R, Angrist B, Wolf AP. 1993. Reproducibility of repeated measures of carbon-11-raclopride binding in the human brain. J Nucl Med 34: 609-613.
34. Volkow ND, Wang GJ, Fowler JS, Logan J, Hitzemann R, Ding YS, Pappas N, Shea C, Piscani K. 1996. Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcohol Clin Exp Res 20: 1594-1598.
35. 2 receptors in alcoholics: A preliminary study. Psychiatry Res 116: 163-172.
36. Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Childress AR, Jayne M, Ma Y, Wong C. 2006. Cocaine cues and dopamine in dorsal striatum: Mechanism of craving in cocaine addiction. J Neurosci 26: 6583-6588.
37. Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Jayne M, Ma Y, Pradhan K, Wong C. 2007. Profound decreases in dopamine release in striatum in detoxified alcoholics: Possible orbitofrontal involvement. J Neurosci 27: 12700-12706.
38. Weiss F, Parsons LH, Schulteis G, Hyytia P, Lorang MT, Bloom FE, Koob GF. 1996. Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats. J Neurosci 16: 3474-3485.
39. Wong DF, Kuwabara H, Schretlen DJ, Bonson KR, Zhou Y, Nandi A, Brasic JR, Kimes AS, Maris MA, Kumar A, Contoreggi C, Links J, Ernst M, Rousset O, Zukin S, Grace AA, Lee JS, Rohde C, Jasinski DR, Gjedde A, London ED. 2006. Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving. Neuropsychopharmacology 31: 2716-2727.
40. Yoder KK, Constantinescu CC, Kareken DA, Normandin MD, Cheng TE, O'Connor SJ, Morris ED. 2007. Heterogeneous effects of alcohol on dopamine release in the striatum: A PET study. Alcohol Clin Exp Res 31: 965-973.
41. Yoder KK, Kareken DA, Morris ED. 2008. What were they thinking? Cognitive states may influence [(11)C]raclopride binding potential in the striatum. Neurosci Lett 430: 38-42.
42. Yoder KK, Morris ED, Constantinescu CC, Cheng TE, Normandin MD, O'Connor SJ, Kareken DA. 2009. When what you see isn't what you get: Alcohol cues, alcohol administration, prediction error, and human striatal dopamine. Alcohol Clin Exp Res 33: 139-149.
43. 3H]raclopride binding in the rat brain. Synapse 9: 188-194.
44. Ziolko SK, Weissfeld LA, Klunk WE, Mathis CA, Hoge JA, Lopresti BJ, DeKosky ST, Price JC. 2006. Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer's disease. Neuroimage 33: 94-102.